Nan Fung Group Holdings’s Harmony Biosciences HRMY Stock Holding History

Nan Fung Group Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$985K	Hold	27,049	–	–	0.75%	18
2026 Q1	$758K	Hold	27,049	–	–	0.62%	20
2025 Q4	$1.01M	Hold	27,049	–	–	0.91%	19
2025 Q3	$745K	Sell	27,049 -341,616	-93%	-$11.8M	1.25%	18
2025 Q2	$11.6M	Hold	368,665	–	–	18.37%	1
2025 Q1	$12.2M	Hold	368,665	–	–	9.98%	1
2024 Q4	$12.7M	Hold	368,665	–	–	10.85%	2
2024 Q3	$14.7M	Hold	368,665	–	–	12.7%	2
2024 Q2	$11.1M	Hold	368,665	–	–	11.87%	2
2024 Q1	$12.4M	Hold	368,665	–	–	11.47%	2
2023 Q4	$11.9M	Hold	368,665	–	–	7.42%	3
2023 Q3	$12.1M	Hold	368,665	–	–	9.78%	3
2023 Q2	$13M	Hold	368,665	–	–	8.29%	3
2023 Q1	$12M	Hold	368,665	–	–	8.19%	3
2022 Q4	$20.3M	Sell	368,665 -142,313	-28%	-$7.82M	14%	3
2022 Q3	$22.6M	Sell	510,978 -125,000	-20%	-$6.1M	14.44%	3
2022 Q2	$31M	Sell	635,978 -132,730	-17%	-$5.98M	21.3%	1
2022 Q1	$37.4M	Hold	768,708	–	–	17.74%	2
2021 Q4	$32.8M	Hold	768,708	–	–	9.7%	3
2021 Q3	$29.5M	Hold	768,708	–	–	9.43%	3
2021 Q2	$21.7M	Buy	+768,708	New	+$23.1M	6.74%	4

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nan Fung Group Holdings's HRMY Position: Q2 2026 in Review

Nan Fung Group Holdings held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 27,049 shares worth $985K. The position accounts for 0.75% of the portfolio, ranked #18.

Nan Fung Group Holdings first reported a position in HRMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $37.4M in Q1 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Nan Fung Group Holdings held 27,049 shares of Harmony Biosciences worth $985K as of Q2 2026.
Nan Fung Group Holdings left its Harmony Biosciences share count unchanged in Q2 2026.
Harmony Biosciences made up 0.75% of Nan Fung Group Holdings's portfolio in Q2 2026, its #18 holding.
Nan Fung Group Holdings first reported a position in Harmony Biosciences in Q2 2021 and has held it in 21 quarters since.
Nan Fung Group Holdings's Harmony Biosciences position peaked at $37.4M in Q1 2022.
328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.